Human TREM2 Antibody
Human TREM2 Antibody Summary
His19-Ser174
Accession # Q9NZC2
Applications
This antibody functions as an ELISA detection antibody when paired with Mouse Anti-Human TREM2 Monoclonal Antibody.
This product is intended for assay development on various assay platforms requiring antibody pairs. We recommend the Human TREM2 DuoSet ELISA Kit (Catalog # DY1828-05) for convenient development of a sandwich ELISA.
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
View Larger
Detection of Human TREM2 by Western Blot. Western blot shows lysates of THP-1 human acute monocytic leukemia cell line. PVDF membrane was probed with 0.2 µg/mL of Goat Anti-Human TREM2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1828) followed by HRP-conjugated Anti-Goat IgG Secondary Antibody (Catalog # HAF109). A specific band was detected for TREM2 at approximately 28 kDa (as indicated). This experiment was conducted under reducing conditions and using Immunoblot Buffer Group 1.
View Larger
TREM2 in Human Dendritic Cells. TREM2 was detected in immersion fixed immature human dendritic cells using Goat Anti-Human TREM2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1828) at 10 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Goat IgG Secondary Antibody (red; Catalog # NL001) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.
View Larger
Human TREM2 ELISA Standard Curve. Recombinant Human TREM2 protein was serially diluted 2-fold and captured by Mouse Anti-Human TREM2 Monoclonal Antibody(Catalog # MAB18281) coated on a Clear Polystyrene Microplate (Catalog # DY990). Goat Anti-Human TREM2 Antigen Affinity-purified Polyclonal Antibody (Catalog # AF1828) was biotinylated and incubated with the protein captured on the plate. Detection of the standard curve was achieved by incubating Streptavidin-HRP (Catalog # DY998) followed by Substrate Solution (Catalog # DY999) and stopping the enzymatic reaction with Stop Solution (Catalog # DY994).
View Larger
Detection of Human TREM2 by Western Blot TREM2 is shed at a single cleavage site in the ectodomain between histidine 157 and serine 158Regulated intramembrane proteolysis of TREM2. ADAM10 initiates proteolytic processing of TREM2 by liberating its ectodomain (sTREM2). Subsequent processing of the membrane retained C‐terminal fragment (CTF) by gamma ‐secretase within the transmembrane domain (TM) releases the intracellular domain (ICD) into the cytosol. A short p3‐like peptide (Haass et al, 1993) may be secreted.Outline of strategy I for mass spectrometric (MS) determination of the N‐terminal end of the TREM2 CTF enriched upon gamma ‐secretase inhibition using DAPT.Western blot analysis of TREM2 stably expressed in HEK293 Flp‐In cells upon gamma ‐secretase inhibition using DAPT. Application of DAPT leads to a robust accumulation of the TREM2 CTF under constitutive conditions as well as upon phorbol 12‐myristate 13‐acetate (PMA) mediated stimulation of TREM2 ectodomain shedding. The TREM2 9D11 antibody raised against the TREM2 C‐terminus was used to detect TREM2, and calnexin levels were analyzed as a loading control. Here, as in all other Western blots in Figs 1 and 2, the two lanes represent samples from two separate wells seeded at the same time.MALDI‐TOF MS determination of the ectodomain cleavage site by immunoprecipitation of TREM2 CTF. The peak at 8,841.48 Da corresponds to a single cleavage site between histidine 157 and serine 158. Very minor additional peaks may represent cellular degradation products, as the N‐terminal counterpart cannot be observed (see Fig 1I).Stimulation of ectodomain shedding by PMA leads to strong increases in sTREM2 (anti‐HA, upper panel) and sAPP alpha (2D8, lower panel). DMSO served as a vehicle control. EV, empty vector control.MALDI‐TOF MS determination of the ectodomain cleavage site upon ADAM17 stimulation using PMA. TREM2 CTFs were enriched by gamma ‐secretase inhibition using DAPT (Fig 1C). The peak at 8,837.09 Da corresponds to a single cleavage site between histidine 157 and serine 158.Outline of strategy II for MS determination of the C‐terminal end of sTREM2 generated by ectodomain shedding.Western blot analysis of full‐length TREM2‐TEVFlag (middle panel) and ectodomain shedding (upper panel) upon transient transfection of HEK293 Flp‐In cells. EV, empty vector control.MALDI‐TOF MS determination of the ectodomain cleavage site following the strategy outlined in Fig 1G. The peak at a mass of 3,947.78 Da corresponds to cleavage C‐terminal of histidine 157 and is absent in cells transfected with an empty expression vector.TREM2 is shed predominantly C‐terminal to histidine 157 as observed in two different cell types as well as under constitutive and PMA‐stimulated conditions.Western blot analysis of full‐length TREM2‐TEVFlag (middle panel) and ectodomain shedding (upper panel) upon transient transfection of THP‐1 monocytes.MALDI‐TOF MS determination of the ectodomain cleavage site in THP‐1 monocytes following the strategy outlined in Fig 1G. The peak at a mass of 3,943.80 Da corresponds to cleavage C‐terminal of histidine 157 and is absent in cells transfected with an empty expression vector.Source data are available online for this figure. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/28855300), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TREM2
TREM2 (Triggering Receptor Expressed on Myeloid cells-2) is a 35 kDa molecular weight type I transmembrane member of the TREM family and Ig superfamily. Mature human TREM2 consists of a 156 amino acid (aa) extracellular domain (ECD) with one V-type Ig-like domain, a 21 aa transmembrane (TM) domain, and a 35 aa cytoplasmic tail. Within the ECD, human TREM2 shares 73% and 74% aa sequence identity with mouse and rat TREM2, respectively. Two closely related transcripts were reported in mouse and designated TREM2a and TREM2b. Soluble forms of the TREM2 ECD are generated by alternative splicing or proteolytic cleavage, and the cytoplasmic domain can be liberated by gamma-Secretase mediated intramembrane cleavage. It is a pattern recognition receptor that binds anionic ligands. A positively charged lysine within the transmembrane segment allows association with the signal adapter protein, DAP12 to deliver an activating signal that plays a role in both innate and adaptive immune responses, including inhibition of macrophage activation. TREM2 is expressed on macrophages, immature myeloid dendritic cells, osteoclasts, microglia, and adipocytes. It promotes the differentiation and function of osteoclasts, the production of inflammatory cytokines by adipocytes, insulin resistance, and the phagocytic clearance of bacteria. In the CNS, TREM2 binds to ApoE, ApoA1, and ApoB and mediates the clearance of apoptotic neurons, amyloid plaques, and cell debris following demyelination. TREM2 also interacts with and modifies signaling through Plexin A1 on dendritic cells and osteoclasts. Mutations in TREM2 or DAP12 are associated with the development of Alzheimer's disease and Nasu-Hakola disease (NHD/PLOSL) which is characterized by presenile dementia and bone cysts. Soluble TREM2 is elevated in cerebrospinal fluid of patients with active multiple sclerosis (MS), and TREM2 blockade exacerbates disease symptoms in the experimental EAE model of MS.
Product Datasheets
Citations for Human TREM2 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
32
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
Human induced pluripotent stem cell-derived microglia with a CX3CR1-V249I genetic variant exhibit dysfunctional phenotypes and modulate neuronal growth and function
Authors: Tutrow, KD;Harkin, J;Varghese, L;Hernandez, M;Huang, KC;Fang, Y;Wilcox, P;Bedford, L;Lin, TY;Zhang, C;Gomes, C;Puntambekar, S;Bissel, S;Lamb, BT;Meyer, JS;
bioRxiv : the preprint server for biology
Species: Human
Sample Types: Whole Cells
Applications: Immunocytochemistry -
Proteo-genomics of soluble TREM2 in cerebrospinal fluid provides novel insights and identifies novel modulators for Alzheimer's disease
Authors: Wang, L;Nykänen, NP;Western, D;Gorijala, P;Timsina, J;Li, F;Wang, Z;Ali, M;Yang, C;Liu, M;Brock, W;Marquié, M;Boada, M;Alvarez, I;Aguilar, M;Pastor, P;Ruiz, A;Puerta, R;Orellana, A;Rutledge, J;Oh, H;Greicius, MD;Le Guen, Y;Perrin, RJ;Wyss-Coray, T;Jefferson, A;Hohman, TJ;Graff-Radford, N;Mori, H;Goate, A;Levin, J;Sung, YJ;Cruchaga, C;
Molecular neurodegeneration
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Exposure of iPSC-derived human microglia to brain substrates enables the generation and manipulation of diverse transcriptional states in vitro
Authors: Dolan, MJ;Therrien, M;Jereb, S;Kamath, T;Gazestani, V;Atkeson, T;Marsh, SE;Goeva, A;Lojek, NM;Murphy, S;White, CM;Joung, J;Liu, B;Limone, F;Eggan, K;Hacohen, N;Bernstein, BE;Glass, CK;Leinonen, V;Blurton-Jones, M;Zhang, F;Epstein, CB;Macosko, EZ;Stevens, B;
Nature immunology
Species: Human
Sample Types: Whole Cells
Applications: ICC -
A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer's disease models
Authors: B van Lenger, L Zhan, D Xia, D Chan, D Joy, JI Park, D Tatarakis, M Calvert, S Hummel, S Lianoglou, ME Pizzo, R Prorok, E Thomsen, LM Bartos, P Beumers, A Capell, SS Davis, L de Weerd, JC Dugas, J Duque, T Earr, K Gadkar, T Giese, A Gill, J Gnörich, C Ha, M Kannuswamy, DJ Kim, ST Kunte, LH Kunze, D Lac, K Lechtenber, AW Leung, CC Liang, I Lopez, P McQuade, A Modi, VO Torres, HN Nguyen, I Pesämaa, N Propson, M Reich, Y Robles-Col, K Schlepckow, L Slemann, H Solanoy, JH Suh, RG Thorne, C Vieira, K Wind-Mark, K Xiong, YJY Zuchero, D Diaz, MS Dennis, F Huang, K Scearce-Le, RJ Watts, C Haass, JW Lewcock, G Di Paolo, M Brendel, PE Sanchez, KM Monroe
Nature Neuroscience, 2023-01-12;0(0):.
Species: Human
Sample Types: Cell Lysates, Recombinant Protein
Applications: Immunoprecipitation, Western Blot -
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Authors: CB Pantazis, A Yang, E Lara, JA McDonough, C Blauwendra, L Peng, H Oguro, J Kanaujiya, J Zou, D Sebesta, G Pratt, E Cross, J Blockwick, P Buxton, L Kinner-Bib, C Medura, C Tompkins, S Hughes, M Santiana, F Faghri, MA Nalls, D Vitale, S Ballard, YA Qi, DM Ramos, KM Anderson, J Stadler, P Narayan, J Papademetr, L Reilly, MP Nelson, S Aggarwal, LU Rosen, P Kirwan, V Pisupati, SL Coon, SW Scholz, T Priebe, M Öttl, J Dong, M Meijer, LJM Janssen, VS Lourenco, R van der Ka, D Crusius, D Paquet, AC Raulin, G Bu, A Held, BJ Wainger, RMC Gabriele, JM Casey, S Wray, D Abu-Bonsra, CL Parish, MS Beccari, DW Cleveland, E Li, IVL Rose, M Kampmann, C Calatayud, P Verstreken, L Heinrich, MY Chen, B Schüle, D Dou, ELF Holzbaur, MC Zanellati, R Basundra, M Deshmukh, S Cohen, R Khanna, M Raman, ZS Nevin, M Matia, J Van Lent, V Timmerman, BR Conklin, K Johnson Ch, K Zhang, S Funes, DA Bosco, L Erlebach, M Welzer, D Kronenberg, G Lyu, E Arenas, E Coccia, L Sarrafha, T Ahfeldt, JC Marioni, WC Skarnes, MR Cookson, ME Ward, FT Merkle
Cell Stem Cell, 2022-12-01;29(12):1685-1702.e22.
Species: Human
Sample Types: Transfected Whole Cells
Applications: ICC -
Sulfavant A as the first synthetic TREM2 ligand discloses a homeostatic response of dendritic cells after receptor engagement
Authors: Carmela Gallo, Emiliano Manzo, Giusi Barra, Laura Fioretto, Marcello Ziaco, Genoveffa Nuzzo et al.
Cellular and Molecular Life Sciences
Species: Human
Sample Types: Whole Cells
Applications: Neutralization -
Absence of microglia promotes diverse pathologies and early lethality in Alzheimer's disease mice
Authors: S Kiani Shab, S Morabito, EP Danhash, A McQuade, JR Sanchez, E Miyoshi, JP Chadarevia, C Claes, MA Coburn, J Hasselmann, J Hidalgo, KN Tran, AC Martini, W Chang Roth, J Pascual, E Head, DA Hume, C Pridans, H Davtyan, V Swarup, M Blurton-Jo
Cell Reports, 2022-06-14;39(11):110961.
Species: Mouse
Sample Types: Tissue Homogenates
Applications: Western Blot -
PLCgamma2 regulates TREM2 signalling and integrin-mediated adhesion and migration of human iPSC-derived macrophages
Authors: J Obst, HL Hall-Rober, TB Smith, M Kreuzer, L Magno, E Di Daniel, JB Davis, E Mead
Scientific Reports, 2021-10-06;11(1):19842.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay -
Improved modeling of human AD with an automated culturing platform for iPSC neurons, astrocytes and microglia
Authors: R Bassil, K Shields, K Granger, I Zein, S Ng, B Chih
Nature Communications, 2021-09-01;12(1):5220.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
Reporter cell assay for human CD33 validated by specific antibodies and human iPSC-derived microglia
Authors: J Wi beta feld, M Mathews, O Mossad, P Picardi, A Cinti, L Redaelli, L Pradier, O Brüstle, H Neumann
Scientific Reports, 2021-06-29;11(1):13462.
Species: Human
Sample Types: Whole Cells
Applications: Stimulation -
MEK1/2 activity modulates TREM2 cell surface recruitment
Authors: J Schapansky, YY Grinberg, DM Osiecki, EA Freeman, SG Walker, E Karran, SM Gopalakris, RV Talanian
The Journal of Biological Chemistry, 2020-12-25;296(0):100218.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
TREM2 Alzheimer's variant R47H causes similar transcriptional dysregulation to knockout, yet only subtle functional phenotypes in human iPSC-derived macrophages
Authors: H Hall-Rober, D Agarwal, J Obst, TB Smith, J Monzón-San, E Di Daniel, C Webber, WS James, E Mead, JB Davis, SA Cowley
Alzheimers Res Ther, 2020-11-16;12(1):151.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay, ICC, Western Blot -
Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer's disease
Authors: A McQuade, YJ Kang, J Hasselmann, A Jairaman, A Sotelo, M Coburn, SK Shabestari, JP Chadarevia, G Fote, CH Tu, E Danhash, J Silva, E Martinez, C Cotman, GA Prieto, LM Thompson, JS Steffan, I Smith, H Davtyan, M Cahalan, H Cho, M Blurton-Jo
Nat Commun, 2020-10-23;11(1):5370.
Species: Human
Sample Types: Cell Lysates, Whole Cells
Applications: Functional Assay, Western Blot -
Cerebrospinal fluid sTREM2 in Alzheimer's disease: comparisons between clinical presentation and AT classification
Authors: AB Knapskog, K Henjum, AV Idland, RS Eldholm, K Persson, I Saltvedt, LO Watne, K Engedal, LNG Nilsson
Sci Rep, 2020-09-28;10(1):15886.
Species: Human
Sample Types: CSF
Applications: ELISA Capture -
Alzheimer's-associated PLCgamma2 is a signaling node required for both TREM2 function and the inflammatory response in human microglia
Authors: BJ Andreone, L Przybyla, C Llapashtic, A Rana, SS Davis, B van Lenger, K Lin, J Shi, Y Mei, G Astarita, G Di Paolo, T Sandmann, KM Monroe, JW Lewcock
Nat. Neurosci., 2020-06-08;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: ICC -
A CX3CR1 Reporter hESC Line Facilitates Integrative Analysis of In-Vitro-Derived Microglia and Improved Microglia Identity upon Neuron-Glia Co-culture
Authors: A Grubman, TH Vandekolk, J Schröder, G Sun, J Hatwell-Hu, J Chan, M Oksanen, S Lehtonen, C Hunt, JE Koistinaho, SK Nilsson, JM Haynes, CW Pouton, JM Polo
Stem Cell Reports, 2020-05-21;14(6):1018-1032.
Species: Human
Sample Types: Whole Cells
Applications: Flow Cytometry -
Enhancing protective microglial activities with a dual function TREM2 antibody to the stalk region
Authors: K Schlepckow, KM Monroe, G Kleinberge, L Cantuti-Ca, S Parhizkar, D Xia, M Willem, G Werner, N Pettkus, B Brunner, A Sülzen, B Nuscher, H Hampel, X Xiang, R Feederle, S Tahirovic, JI Park, R Prorok, C Mahon, CC Liang, J Shi, DJ Kim, H Sabelström, F Huang, G Di Paolo, M Simons, JW Lewcock, C Haass
EMBO Mol Med, 2020-03-10;0(0):e11227.
Species: Human
Sample Types: Cell Culture Lysates
Applications: Western Blot -
Soluble TREM2 ameliorates pathological phenotypes by modulating microglial functions in an Alzheimer's disease model
Authors: L Zhong, Y Xu, R Zhuo, T Wang, K Wang, R Huang, D Wang, Y Gao, Y Zhu, X Sheng, K Chen, N Wang, L Zhu, D Can, Y Marten, M Shinohara, CC Liu, D Du, H Sun, L Wen, H Xu, G Bu, XF Chen
Nat Commun, 2019-03-25;10(1):1365.
Species: Mouse
Sample Types: Cell Lysates, Whole Tissue
Applications: IHC, Western Blot -
Glial activation and inflammation along the Alzheimer's disease continuum
Authors: K Nordengen, BE Kirsebom, K Henjum, P Selnes, B Gísladótti, M Wettergree, SB Torsetnes, GR Grøntvedt, KK Waterloo, D Aarsland, LNG Nilsson, T Fladby
J Neuroinflammation, 2019-02-21;16(1):46.
Species: Human
Sample Types: CSF
Applications: ELISA Development (Capture) -
CSF sTREM2 in delirium-relation to Alzheimer's disease CSF biomarkers A?42, t-tau and p-tau
Authors: K Henjum, E Quist-Paul, H Zetterberg, K Blennow, LNG Nilsson, LO Watne
J Neuroinflammation, 2018-11-03;15(1):304.
Species: Human
Sample Types: CSF
Applications: ELISA Development (Capture) -
Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis
Authors: P Garcia-Rei, A Phillips, TM Piers, C Villegas-L, M Butler, A Mallach, C Rodrigues, CE Arber, A Heslegrave, H Zetterberg, H Neumann, S Neame, H Houlden, J Hardy, JM Pocock
Cell Rep, 2018-08-28;24(9):2300-2311.
Species: Human
Sample Types:
-
Small nuclear RNA-mediated modulation of splicing reveals a therapeutic strategy for a TREM2 mutation and its post-transcriptional regulation
Authors: M Yanaizu, K Sakai, Y Tosaki, Y Kino, JI Satoh
Sci Rep, 2018-05-02;8(1):6937.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
TREM2 Is a Receptor for ?-Amyloid that Mediates Microglial Function
Authors: Y Zhao, X Wu, X Li, LL Jiang, X Gui, Y Liu, Y Sun, B Zhu, JC Piña-Cresp, M Zhang, N Zhang, X Chen, G Bu, Z An, TY Huang, H Xu
Neuron, 2018-03-07;97(5):1023-1031.e7.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models
Authors: CYD Lee, A Daggett, X Gu, LL Jiang, P Langfelder, X Li, N Wang, Y Zhao, CS Park, Y Cooper, I Ferando, I Mody, G Coppola, H Xu, XW Yang
Neuron, 2018-03-07;97(5):1032-1048.e5.
Species: Transgenic Mouse
Sample Types: Tissue Homogenates
Applications: Western Blot -
Intracellular trafficking of TREM2 is regulated by presenilin 1
Authors: Y Zhao, X Li, T Huang, LL Jiang, Z Tan, M Zhang, IH Cheng, X Wang, G Bu, YW Zhang, Q Wang, H Xu
Exp. Mol. Med., 2017-12-01;49(12):e405.
Species: Human
Sample Types: Protein
Applications: Western Blot -
TREM2 shedding by cleavage at the H157-S158 bond is accelerated for the Alzheimer's disease-associated H157Y variant
Authors: P Thornton, J Sevalle, MJ Deery, G Fraser, Y Zhou, S Ståhl, EH Franssen, RB Dodd, S Qamar, B Gomez Pere, LS Nicol, S Eketjäll, J Revell, C Jones, A Billinton, PH St George-, I Chessell, DC Crowther
EMBO Mol Med, 2017-10-01;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function
Authors: K Schlepckow, G Kleinberge, A Fukumori, R Feederle, SF Lichtentha, H Steiner, C Haass
EMBO Mol Med, 2017-10-01;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
A split-luciferase complementation, real-time reporting assay enables monitoring of the disease-associated transmembrane protein TREM2 in live cells
Authors: MM Varnum, KA Clayton, A Yoshii-Kit, G Yonemoto, L Koro, S Ikezu, T Ikezu
J. Biol. Chem., 2017-05-10;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Functional Assay -
TREM-2 promotes acquired cholesteatoma-induced bone destruction by modulating TLR4 signaling pathway and osteoclasts activation
Sci Rep, 2016-12-09;6(0):38761.
Species: Human
Sample Types: Whole Tissue
Applications: IHC-Fr -
Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-gamma in human osteoclast precursors.
Authors: Ji JD, Park-Min KH, Shen Z, Fajardo RJ, Goldring SR, McHugh KP, Ivashkiv LB
J. Immunol., 2009-11-04;183(11):7223-33.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression.
Authors: Park-Min KH, Ji JD, Antoniv T, Reid AC, Silver RB, Humphrey MB, Nakamura M, Ivashkiv LB
J. Immunol., 2009-07-22;183(4):2444-55.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
TREM-2 binds to lipooligosaccharides of Neisseria gonorrhoeae and is expressed on reproductive tract epithelial cells.
Authors: Quan DN, Cooper MD, Potter JL, Roberts MH, Cheng H, Jarvis GA
Mucosal Immunol, 2008-03-05;1(3):229-38.
Species: Human
Sample Types: Whole Tissue
Applications: IHC
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human TREM2 Antibody
Average Rating: 4.8 (Based on 4 Reviews)
Have you used Human TREM2 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Filter by:
HEK293T cell stably expressing human TREM2
